Products Resources产品中心
CONTACT US
-
400 179 0116
24-hour service hotline
Products Description
The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma. The patient had preoperative chemotherapy (Thiotepa). The cells have a reported plating efficiency of 41%.
